Review Article Published: November 2009 The bladder extracellular matrix. Part I: architecture, development and disease Karen J. Aitken & Darius J. Bägli Nature Reviews Urology 6, 596–611 (2009 ...

Zünd is showing how it combines intelligent cutting systems and software to boost productive composites environments.

NAFILean materials family blends low-carbon recycled plastics and renewable post-consumer sources to provide a sustainable, ...

LOS ANGELES, CA– In a groundbreaking achievement set to reshape the future of transplant medicine, Dr. Inderbir S. Gill has led the world’s first successful bladder transplant in a human being ...

AstraZeneca AZN announced that the European Commission has approved its blockbuster cancer drug, Imfinzi (durvalumab), for a ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales expectations for the drug, even though it recently failed a second ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from ...